<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20251121068065N10</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-06-30</date_registration>
      <primary_sponsor>Shahre-kord University of Medical Sciences</primary_sponsor>
      <public_title>Comparison of the effect of immediate and routine kangaroo mother care on the outcomes and physiological indicators of premature babies hospitalized in the neonatal intensive care unit</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of the effect of immediate and routine kangaroo mother care on the outcomes and physiological indicators of premature babies hospitalized in the neonatal intensive care unit</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-07-01</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>52</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/90942</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: Stratified block randomization will be performed according to gestational age, with participants stratified into two categories (≤32 weeks and 33–37 weeks of gestation). Within each stratum, participants will be randomly allocated to the intervention or control group using permuted blocks of sizes 4 and 6 with a 1:1 allocation ratio. Allocation concealment will be ensured through sequentially numbered, sealed, opaque envelopes that are opened only after participant enrollment. Blocks will be filled progressively within each stratum until the required sample size of 52 participants is achieved, ensuring balanced allocation between study groups.</study_design>
      <phase>N/A</phase>
      <hc_freetext>The effect of kangaroo care on adverse outcomes and physiological indicators of premature infants.</hc_freetext>
      <i_freetext>Intervention 1: Control group (Routine Kangaroo Care): Preterm infants will receive skin-to-skin care after stabilization of physiological status, typically initiated approximately 3 days after birth, according to routine clinical practice. In this method, the mother is positioned in a semi-upright sitting posture on a kangaroo mother care (KMC) chair. The infant, wearing only a diaper and a cap, is placed in an upright position—commonly referred to as the “frog position”—on the mother’s chest between the breasts to ensure direct skin-to-skin contact. Intervention 2: Intervention group (Immediate Kangaroo Care): Preterm infants will receive early skin-to-skin contact with their mothers within 10 minutes to 24 hours after birth. The infant will be placed directly on the mother’s chest to establish continuous skin-to-skin contact.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no further information.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Dr. Roya Choupani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of Medicine, Rahmatieh Educational Complex, Shahrekord, Iran.</address>
        <city>Shahrekord</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۸۸۱۵۷۱۳۴۷۱</zip>
        <telephone>+98 913 721 5546</telephone>
        <email>royachoopani51@gmail.com</email>
        <affiliation>Shahre-kord University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr. Jafar Moghaddasi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of Nursing and Midwifery, Shahrekord University of Medical Sciences, Rahmatieh, Shahrekord, Chaharmahal and Bakhtiari Province, Iran</address>
        <city>Shahrekord</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۸۸۱۵۷۱۳۴۷۱</zip>
        <telephone>+98 913 181 1328</telephone>
        <email>moghaddasi@skums.ac.ir</email>
        <affiliation>Shahre-kord University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Gestational age minimum 26 weeks and maximum 37 weeks.
Absence of major congenital anomalies (e.g., diaphragmatic hernia, gastroschisis, omphalocele, or meningomyelocele).
Initiation of the intervention within the first 24 hours after birth.
Stable respiratory status with no increase in ventilator settings during the 6 hours preceding the intervention.
Written informed consent obtained from parents or legal guardians.
No active bleeding.
Absence of a central venous catheter, peripherally inserted central catheter (PICC), chest tube, or umbilical arterial catheter.
Singleton or twin birth.</inclusion_criteria>
      <agemin>no limit</agemin>
      <agemax>no limit</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Requirement for increased ventilator support during the study period.
Withdrawal of parental consent.
Hemodynamic instability requiring pharmacological intervention.
Severe respiratory distress.
Infant death during the study period.
Requirement for surgical intervention.
Discharge from the neonatal unit before completion of the study.
Transfer to another healthcare facility or inability to complete follow-up assessments.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>P07.3</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Preterm [premature] newborn [other]</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Control group (Routine Kangaroo Care): Preterm infants will receive skin-to-skin care after stabilization of physiological status, typically initiated approximately 3 days after birth, according to routine clinical practice. In this method, the mother is positioned in a semi-upright sitting posture on a kangaroo mother care (KMC) chair. The infant, wearing only a diaper and a cap, is placed in an upright position—commonly referred to as the “frog position”—on the mother’s chest between the breasts to ensure direct skin-to-skin contact.</i_keyword>
      <i_keyword>Intervention group (Immediate Kangaroo Care): Preterm infants will receive early skin-to-skin contact with their mothers within 10 minutes to 24 hours after birth. The infant will be placed directly on the mother’s chest to establish continuous skin-to-skin contact.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>1. Respiratory rate. Timepoint: Respiratory rate in both groups is assessed 15 minutes before the start of the intervention and 15 minutes after its initiation, and is continuously monitored throughout the hospitalization period. Method of measurement: Respiratory rate is measured manually over one full minute using a stopwatch (Digikala43hs, China).</prim_outcome>
      <prim_outcome>2. Arterial oxygen saturation (SpO₂). Timepoint: Arterial oxygen saturation (SpO₂) in both groups is assessed 15 minutes before the start of the intervention and 15 minutes after its initiation, and is continuously monitored throughout the hospitalization period. Method of measurement: Arterial oxygen saturation is measured using a standard patient monitoring system (ARDP Sect Cardia 10, Sa Iran Company).</prim_outcome>
      <prim_outcome>3. Blood sugar. Timepoint: Blood sugar in both groups is assessed 15 minutes before the start of the intervention and 15 minutes after its initiation, and is continuously monitored throughout the hospitalization period. Method of measurement: Blood glucose is measured using a glucometer (eBsensor, Taiwan) via heel-prick sampling once per shift due to its invasive nature.</prim_outcome>
      <prim_outcome>4. Time to full nutrition. Timepoint: The time of initiation of oral or breast milk feeding will be recorded after birth. From the start of feeding, infants will be followed continuously during NICU hospitalization until full enteral feeding is achieved. Method of measurement: Nutritional status and attainment of full feeding will be assessed based on gestational age–specific criteria. In infants with gestational age &lt;32 weeks, full feeding is defined as achieving an enteral intake of 150 mL/kg/day. In infants with gestational age 32–37 weeks, attainment of exclusive breastfeeding (BF) is considered as optimal nutrition.</prim_outcome>
      <prim_outcome>5. Time to ideal weight. Timepoint: Weight is measured daily. Method of measurement: Body weight is measured daily at 9 PM using a digital scale (Taiwan-made, accuracy ±5 g). Measurements are performed with the infant wearing a dry diaper and no clothing. The weight of the diaper is measured separately and subtracted from the total weight to obtain the net body weight.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Sepsis. Timepoint: Sepsis will be assessed throughout the hospitalization period, from initiation of the intervention until discharge from the neonatal intensive care unit (NICU) or death of the infant, whichever occurs first. Method of measurement: Sepsis will be diagnosed according to the standard neonatal sepsis criteria routinely used in the neonatal intensive care unit. Diagnosis will be based on the presence of clinical signs documented in the medical record and confirmation by a positive blood culture (BACTEC), as determined by the attending neonatologist. The outcome will be recorded as a dichotomous variable (yes/no).</sec_outcome>
      <sec_outcome>Intracerebral hemorrhage. Timepoint: Intracranial hemorrhage will be assessed from the initiation of the intervention until discharge from the neonatal intensive care unit or death of the infant, whichever occurs first. Method of measurement: Intracranial hemorrhage will be diagnosed based on cranial ultrasonography findings indicating bleeding within the brain and confirmed by a neonatologist. The diagnosis will be documented in the patient's medical record and recorded as a dichotomous variable (yes/no).</sec_outcome>
      <sec_outcome>Necrotizing enterocolitis (NEC). Timepoint: Necrotizing enterocolitis will be assessed daily from the initiation of the intervention until discharge from the neonatal intensive care unit. Method of measurement: Diagnosis based on clinical symptoms and diagnostic findings recorded in the patient's chart including abdominal distension, feeding intolerance, gastric lavage, and diagnosis by a neonatologist. The variable is recorded qualitatively (yes/no). Recording tools include feeding form, lavage form, and abdominal circumference measurement.</sec_outcome>
      <sec_outcome>Neonatal death. Timepoint: Neonatal mortality will be assessed daily from the initiation of the intervention until discharge from the neonatal intensive care unit (NICU) or death of the infant, whichever occurs first. Method of measurement: Neonatal mortality will be determined based on documented death during the hospitalization period and recorded as a dichotomous outcome (yes/no).</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shahre-kord University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2026-05-17</approval_date>
        <contact_name>Research Ethics Committee of Shahrekord and Borujen Faculties of Nursing and Midwifery and School of</contact_name>
        <contact_address>Building No. 2, University Headquarters, Kashani Boulevard, Shahrekord, Iran. Shahrekord Chahar-Mahal-va-Bakhtiari Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
